We are live on ! Find out more
NSRI

New Silk Road Investment Portfolio holdings

AUM $50.4M
1-Year Est. Return 32.31%
This Fund
S&P 500
This Quarter Est. Return
+1.3%
1 Year Est. Return
+32.31%
3 Year Est. Return
-21.21%
5 Year Est. Return
+10.41%
10 Year Est. Return
AUM
$189M
AUM Growth
-$2.14M
Cap. Flow
-$4.95M
Cap. Flow %
-2.62%
Top 10 Hldgs %
100%
Holding
10
New
1
Increased
2
Reduced
1
Closed
2

Top Buys

Rank Stock Value
1
MMYT icon
MakeMyTrip
MMYT
+$9.41M
2
BZUN
Baozun
BZUN
+$5.04M
3
EDU icon
New Oriental
EDU
+$697K

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 82%
2 Financials 14.39%
3 Consumer Staples 2.57%
4 Technology 1.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BABA icon
1
Alibaba
BABA
$289B
$129M 68.34%
749,882
-11,600
-2% -$2.08M
HDB icon
2
HDFC Bank
HDB
$123B
$27.2M 14.39%
1,071,200
MMYT icon
3
MakeMyTrip
MMYT
$5.32B
$17.7M 9.38%
594,291
+340,400
+134% +$9.41M
BZUN
4
Baozun
BZUN
$168M
$4.93M 2.6%
+156,153
New +$5.04M
EDU icon
5
New Oriental
EDU
$9.38B
$3.37M 1.78%
35,850
+7,850
+28% +$697K
TTM
6
DELISTED
Tata Motors Limited
TTM
$3.18M 1.68%
96,271
INFY icon
7
Infosys
INFY
$48.4B
$1.96M 1.04%
242,200
VSA
8
VisionSys AI
VSA
$8.07M
$1.5M 0.79%
40
GSUM
9
DELISTED
Gridsum Holding Inc.
GSUM
-53,600
Closed -$552K
CBPO
10
DELISTED
China Biologic Products Holdings, Inc.
CBPO
-189,395
Closed -$17.5M

Similar funds

New Silk Road Investment's Q4 2017 Portfolio in Review

As of Q4 2017, New Silk Road Investment held 10 positions worth $189M, down 1.1% from $191M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

New Silk Road Investment's Q4 2017 filing shows 1 new, 2 increased, 1 reduced and 2 closed positions. Its largest new stake was Baozun: 156,153 shares worth $4.93M. The largest sale was China Biologic Products Holdings, Inc., an estimated $17.5M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 82% of assets, up from 74% a quarter earlier, followed by Financials and Consumer Staples.

  • New Silk Road Investment's largest Q4 2017 buy was Baozun: 156,153 shares worth $4.93M.
  • New Silk Road Investment added most to MakeMyTrip in Q4 2017, an estimated $9.41M increase.
  • New Silk Road Investment's biggest Q4 2017 reduction was Alibaba, cutting an estimated $2.08M.
  • New Silk Road Investment fully exited China Biologic Products Holdings, Inc. in Q4 2017, selling an estimated $17.5M.
  • New Silk Road Investment's ten largest holdings make up 100% of its $189M portfolio in Q4 2017.
  • New Silk Road Investment opened 1 new position and closed 2 in Q4 2017.
  • New Silk Road Investment's portfolio value fell 1.1% quarter-over-quarter to $189M.

Based on New Silk Road Investment's 13F filing for Q4 2017, filed 10 Jan 2018.